<DOC>
	<DOCNO>NCT02031263</DOCNO>
	<brief_summary>The investigator find bronchial thermoplasty show efficacy reduce acute exacerbation improve quality life uncontrolled asthma Korea research . US FDA approve procedure CE mark take Europe . Many procedure perform Western country . Korean FDA approve procedure 2013 . However , procedure perform Korea , data rare Asian country . In study , investigator examine efficacy procedure Korean asthmatic .</brief_summary>
	<brief_title>Efficacy Bronchial Thermoplasty Korean</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>1 ) Eighteenyearold older 2 ) Patients whose asthma control three month use high dose inhale steroid long act Î²2agonists 3 ) Patients prebronchodilator FEV1 sixty eightyfive % 4 ) Patients improve continuous drug us . 1 ) Presence pacemaker , internal defibrillator , implantable electronic device , 2 ) Known sensitivity medication require perform bronchoscopy , include lidocaine , atropine , benzodiazepine . 3 ) Patients previously treat Alair System retreat area ( ) . No clinical data available study safety and/or effectiveness repeat treatment . 4 ) Active respiratory infection 5 ) Asthma exacerbation change dose systemic corticosteroid asthma ( ) past 14 day . 6 ) Known coagulopathy . 7 ) As bronchoscopic procedure , patient stop take anticoagulant , antiplatelet agent , aspirin NSAIDS procedure physician guidance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>